Fewer than one in five people with psoriasis in Ireland is aware of their increased risk of heart and bowel disease, according to a new study. The study, carried out at University Hospital Waterford, examined patient awareness of co-morbidities associated with psoriasis. What is psoriasis? Psoriasis is an inflammatory condition that causes red, dry, flaky or scaly skin and […]
Eczema Awareness Week is held in September. It coincides with the start of the school year when many households will be adapting to a new routine for children starting or returning to school. With all the excitement and preparation, we are mindful of the children out there with eczema and what this might mean for them. This year […]
Ireland among last countries in EU to make new drug available to patients The ISF is calling on HSE management to reimburse a first-in-class drug (dupilumab) to provide access to hundreds of people living with severe atopic eczema throughout Ireland. In 2017, the European Medicines Agency approved dupilumab (brand name: Dupixent) for the treatment of moderate-to-severe atopic […]
The International Alliance of Dermatology Patient Organisations (IADPO) also known as Global Skin, of which the ISF is a founding member, convened a webinar titled: Understanding COVID-19 & its impacts on dermatology patients. Representatives from patient organisations around the world attended this live ‘townhall’ style meeting which hosted an excellent presentation by Dr Esther Freeman, Assistant Professor of Dermatology […]
Skin cancer is the most common type of cancer in Ireland and in fair/light skinned populations worldwide, for whom sunburn is a risk factor. The vast majority of these cancers are associated with overexposure to ultraviolet radiation (UV), mainly from sunlight. However, UV from artificial sources e.g. sunbeds, also cause skin cancer. Yet, the good news […]
